INS and diabetes mellitus: Oxyntomodulin reduces food intake and increases energy expenditure, leading to significant weight loss in a 28-day clinical study in human volunteers over 28 days [34], and has been shown to improve insulin secretion in short-term clinical studies in people with diabetes [35].